A synthetic peptide for use as a blocking control in assays to test for specificity of LYZ antibody, Alternative Names: LYZ control peptide, LYZ antibody Blocking Peptide, Anti-LYZ Blocking Peptide, lysozyme, renal amyloidosis Blocking Peptide, LZM Blocking Peptide, lysozyme Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
LYZ
(Lysozyme (LYZ))
Hintergrund
LYZ is a human lysozyme, whose natural substrate is the bacterial cell wall peptidoglycan (cleaving the beta[1-4]glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine). Lysozyme is one of the anti-microbial agents found in human milk, and is also present in spleen, lung, kidney, white blood cells, plasma, saliva, and tears. Missense mutations in LYZ have been identified in heritable renal amyloidosis.